With an LDL cholesterol of 114 mg/dL, what medication should be prescribed?

Statin Therapy Should Be Initiated

For an LDL cholesterol of 114 mg/dL, prescribe a moderate-to-high intensity statin as first-line therapy, with the specific choice and intensity determined by the patient's cardiovascular risk category.

Risk Stratification Determines Treatment Intensity

The decision on which statin and what dose depends entirely on cardiovascular risk assessment. Here's the algorithmic approach:

Step 1: Determine Risk Category

Very High Risk (LDL goal <55 mg/dL):

• Established ASCVD (prior MI, stroke, peripheral artery disease)
• Post-acute coronary syndrome
• Progressive CVD with diabetes, CKD stage 3+, or familial hypercholesterolemia 1, 2

High Risk (LDL goal <70-100 mg/dL):

• Diabetes with ≥1 additional risk factor
• CKD stage 3 without other factors
• 10-year ASCVD risk ≥20%
• Age >40 with multiple risk factors 3, 2

Moderate Risk (LDL goal <100-130 mg/dL):

• 10-year ASCVD risk 10-20%
• 2+ risk factors (hypertension, smoking, family history, low HDL) 4

Low Risk (LDL goal <116-160 mg/dL):

• 0-1 risk factors
• 10-year risk <10% 2, 4

Step 2: Select Statin Intensity Based on Risk

For Very High Risk patients with LDL 114 mg/dL:

• Start high-intensity statin immediately: atorvastatin 40-80 mg or rosuvastatin 20-40 mg
• Consider upfront combination therapy with ezetimibe to achieve >50% LDL reduction 1, 2
• Target: LDL <55 mg/dL

For High Risk patients (including diabetes):

• Start moderate-to-high intensity statin: atorvastatin 20-40 mg or rosuvastatin 10-20 mg
• Add lifestyle modifications simultaneously 3
• Target: LDL <70-100 mg/dL depending on specific risk factors

For Moderate Risk patients:

• Start moderate-intensity statin: atorvastatin 10-20 mg, rosuvastatin 5-10 mg, or simvastatin 20-40 mg
• Emphasize therapeutic lifestyle changes 4
• Target: LDL <100-130 mg/dL

For Low Risk patients:

• Lifestyle modifications first
• Consider statin only if LDL remains >160 mg/dL after 3-6 months of diet therapy 4, 5

Specific Prescribing Recommendations

First-Line Statin Choices by Potency:

High-Intensity (lowers LDL 50%+):

• Atorvastatin 40-80 mg daily
• Rosuvastatin 20-40 mg daily 6, 7

Moderate-Intensity (lowers LDL 30-50%):

• Atorvastatin 10-20 mg daily
• Rosuvastatin 5-10 mg daily
• Simvastatin 20-40 mg daily 3

Special Considerations:

Diabetes with metabolic syndrome: Consider pitavastatin with ezetimibe upfront to reduce new-onset diabetes risk, or lower-dose high-intensity statin (rosuvastatin 20 mg or atorvastatin 40 mg) plus ezetimibe 1

Statin intolerance: Use bempedoic acid 180 mg daily if ASCVD present or high risk 7

Treatment Escalation Algorithm

1. Reassess LDL at 4-6 weeks after statin initiation
2. If LDL not at goal: Increase statin dose to maximum tolerated
3. If still not at goal: Add ezetimibe 10 mg daily 1, 8
4. If still not at goal in very high-risk patients: Add PCSK9 inhibitor (evolocumab 140 mg Q2 weeks or alirocumab 75-150 mg Q2 weeks) 7, 8

Critical Pitfalls to Avoid

Don't wait for lifestyle changes alone in high or very high-risk patients—statins should be started immediately regardless of baseline LDL 3. The 2014 diabetes guidelines explicitly state that pharmacological treatment should be added to lifestyle therapy "regardless of baseline lipid levels" in diabetics over 40 with CVD risk factors 3.

Don't undertreate based on "acceptable" LDL levels. An LDL of 114 mg/dL is above goal for anyone with high or very high cardiovascular risk. The most recent 2024 expert panel emphasizes that post-ACS patients should receive combination therapy immediately to achieve LDL <55 mg/dL 1.

Don't use low-intensity statins—they are not recommended unless the patient cannot tolerate higher doses 6, 3.

Monitor adherence closely. The discharge letter approach used in European cardiology departments should include specific LDL targets and escalation timelines to maximize treatment adherence 1.

Concurrent Lifestyle Modifications

While initiating statin therapy:

• Reduce saturated fat and cholesterol intake
• Increase fiber to 25 g/day
• Mediterranean diet pattern preferred
• Regular physical activity
• Weight loss if BMI >25 6, 3

The evidence strongly supports that lower LDL for longer duration is better for cardiovascular risk reduction 9. With an LDL of 114 mg/dL, virtually all patients except those at very low risk should receive statin therapy, with intensity matched to their specific risk category.